Company intelligence / Profile preview

TiumBio Co., Ltd.

Seongnam-si, Gyeonggi-do, South Koreatiumbio.com ↗

Ownership: Private
Development stage: Phase 2

Overview

TiumBio has reported positive results from a Phase 1a clinical trial for its hemophilia treatment TU7710, which showed potential as a long‑acting recombinant activated factor VII. The company has also initiated a Phase 2 trial of its oral immuno-oncology drug TU2218, targeting the TGF‑β pathway. Its GnRH antagonist program for endometriosis has advanced to clinical trials in partnership with Hansoh Pharma

Therapeutic areas: OtherWomen's HealthOncologyHematology
Modalities: Small moleculesBiologics (recombinant proteins)
Industry: Biotech

Drug pipeline

8 assets

tosposertib

7 more assets in the full pipeline.

Request access →

Partnerships

Hansoh Pharma (China): For development and commercialization of Merigolix/TU2670 in reproductive health indications including ART/IVF applications.Oncodesign Société Anonyme (France): Collaboration on fibrosis drug candidates research and development

Beyond the preview

Go deeper on TiumBio Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TiumBio Co., Ltd..

Explore the full profile